Dive Brief: Roche has raised its bet on obesity, agreeing to pay Zealand Pharma $1.65 billion to license an experimental shot the Danish company put into a Phase 2b trial in December, Zealand said Wednesday
Current research suggests that GLP-1 receptor agonists do not have a direct pharmacological mechanism that causes muscle breakdown
Non-peptidic oral GLP-1RAs may eventually reduce supply pressures because they do not require peptide synthesis or cold-chain storage, but this will depend on scalable, cost-efficient manufacturing pathways
doi: 10.1007/s10792-025-03681-5 137 LiYLiuJMaXBaiX
Are There Any Side Effects of Glutathione Injections
In malignant diseases of the hematological system, trace element metabolism is disturbed to varying degrees, affecting the activity of antioxidants and accelerating the diseases development